Functional Characterisation of the Maturation of the Blood-Brain Barrier in Larval Zebrafish

被引:194
作者
Fleming, Angeleen [1 ]
Diekmann, Heike [1 ]
Goldsmith, Paul [1 ]
机构
[1] DanioLabs Ltd, Cambridge, England
关键词
P-GLYCOPROTEIN; TRANSGENIC ZEBRAFISH; VASCULAR DEVELOPMENT; IN-VIVO; GENE; DRUGS; PERMEABILITY; PENETRATION; SEIZURES; MODELS;
D O I
10.1371/journal.pone.0077548
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Zebrafish are becoming increasingly popular as an organism in which to model human disease and to study the effects of small molecules on complex physiological and pathological processes. Since larvae are no more than a few millimetres in length, and can live in volumes as small as 100 microliters, they are particularly amenable to high-throughput and high content compound screening in 96 well plate format. There is a growing literature providing evidence that many compounds show similar pharmacological effects in zebrafish as they do in mammals, and in particular humans. However, a major question regarding their utility for small molecule screening for neurological conditions is whether a molecule will reach its target site within the central nervous system. Studies have shown that Claudin-5 and ZO-1, tight-junction proteins which are essential for blood-brain barrier (BBB) integrity in mammals, can be detected in some cerebral vessels in zebrafish from 3 days post-fertilisation (d.p.f.) onwards and this timing coincides with the retention of dyes, immunoreactive tracers and fluorescent markers within some but not all cerebral vessels. Whilst these findings demonstrate that features of a BBB are first present at 3 d.p.f., it is not clear how quickly the zebrafish BBB matures or how closely the barrier resembles that of mammals. Here, we have combined anatomical analysis by transmission electron microscopy, functional investigation using fluorescent markers and compound uptake using liquid chromatography/tandem mass spectrometry to demonstrate that maturation of the zebrafish BBB occurs between 3 d.p.f. and 10 d.p.f. and that this barrier shares both structural and functional similarities with that of mammals.
引用
收藏
页数:12
相关论文
共 36 条
[1]   Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae [J].
Alderton, W. ;
Berghmans, S. ;
Butler, P. ;
Chassaing, H. ;
Fleming, A. ;
Golder, Z. ;
Richards, F. ;
Gardner, I. .
XENOBIOTICA, 2010, 40 (08) :547-557
[2]   Evolution of the vertebrate ABC gene family: Analysis of gene birth and death [J].
Annilo, Tarmo ;
Chen, Zhang-Qun ;
Shulenin, Sergey ;
Costantino, Julie ;
Thomas, Lauren ;
Lou, Hong ;
Stefanov, Stefan ;
Dean, Michael .
GENOMICS, 2006, 88 (01) :1-11
[3]  
Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130
[4]   P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists [J].
Chen, CP ;
Hanson, E ;
Watson, JW ;
Lee, JS .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (03) :312-318
[5]   The blood-brain barrier in health and disease [J].
Daneman, Richard .
ANNALS OF NEUROLOGY, 2012, 72 (05) :648-672
[6]   The Zebrafish: A Powerful Platform for In Vivo, HTS Drug Discovery [J].
Delvecchio, Chris ;
Tiefenbach, Jens ;
Krause, Henry M. .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2011, 9 (04) :354-361
[7]   Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population [J].
Fukunaga-Kalabis, M. ;
Martinez, G. ;
Nguyen, T. K. ;
Kim, D. ;
Santiago-Walker, A. ;
Roesch, A. ;
Herlyn, M. .
ONCOGENE, 2010, 29 (46) :6115-6124
[8]   DETECTION OF P-GLYCOPROTEIN ISOFORMS BY GENE-SPECIFIC MONOCLONAL-ANTIBODIES [J].
GEORGES, E ;
BRADLEY, G ;
GARIEPY, J ;
LING, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :152-156
[9]   Fluorescence imaging of blood-brain barrier disruption [J].
Hawkins, BT ;
Egleton, RD .
JOURNAL OF NEUROSCIENCE METHODS, 2006, 151 (02) :262-267
[10]   Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs [J].
Hung, Chin-Chuan ;
Chen, Chih-Chuan ;
Lin, Chun-Jung ;
Liou, Horng-Huei .
PHARMACOGENETICS AND GENOMICS, 2008, 18 (05) :390-402